TENS to reduce fatigue in relapsing-remitting multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether TENS, a non-drug device that delivers mild electrical signals through the skin, can reduce fatigue in people with relapsing-remitting multiple sclerosis (MS). It also includes an exercise-training portion and checks safety and comfort during the program.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have relapsing-remitting multiple sclerosis (RRMS)
- You have trouble walking that you’ve noticed yourself
- You take stable MS symptom medicines such as Ampyra, provigil, or similar, and you haven’t had an MS relapse in the last 30 days
- You can attend exercise sessions 3 days per week for 6 weeks and get to the Boulder campus
- You do NOT have certain safety issues (uncorrected vision/hearing problems, metal implants, seizure history, uncontrolled blood pressure, diabetes, or trouble feeling touch/temperature/pain)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two non-invasive brain stimulation treatments—TMS and tDCS—to see if they can reduce fatigue in people with relapsing-remitting MS. The goal is to find a safe, drug-free way to help you feel less tired.
This study tests whether doing exercises at home combined with a non-invasive brain stimulation technique (gentle electrical stimulation on your scalp) can reduce the exhaustion and tiredness that comes with multiple sclerosis. The goal is to see if this combination helps you feel less fatigued and improves your ability to stay active.
This study tests whether using a small electrical nerve stimulator on the skin can help improve symptoms of multiple sclerosis (MS), such as pain or numbness. The treatment is non-invasive and may offer a safe way to manage MS symptoms without medication.
This trial tests a gentle brain stimulation technique called transcranial direct current stimulation (tDCS) to see if it helps improve symptoms in people with multiple sclerosis (MS). It may offer a non-drug option to manage symptoms like fatigue, walking difficulties, or other issues.
This study tests whether a noninvasive brain stimulation technique (rTMS) can help people with multiple sclerosis who have leg stiffness and weakness. You will receive daily sessions over two weeks to see if it improves walking and quality of life.
This study uses a safe, non-invasive brain stimulation technique to see if it can reduce fatigue in people with relapsing-remitting MS. It compares people with and without fatigue to understand how the brain is affected.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.